Endometrial Neoplasms - Drug therapy
Research News and Information

Monday, November 23, 2009

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.

29 Nov 2009 The objective of this study was to evaluate the role of an in vitro drug resistance assay to platinum and taxane in the management of advanced epithelial ovarian, fallopian and primary peritoneal cancer. All patients with FIGO Stage IIIc and IV who ... Read more...

Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.

30 Aug 2009 BACKGROUND: Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and phase 2 trials for endometrial cancer are currently being conducted. Because rapamycin is known to enhance the ... Read more...

Pharmacotherapy of endometrial cancer.

30 Jul 2009 BACKGROUND: Endometrial cancer is the seventh most common malignancy among women worldwide. Despite most cases being diagnosed at an early stage, the death rate has increased steadily over the past 20 years. The lack of an effective, standardized ... Read more...

Latest indexed articles for 'Endometrial Neoplasms - Drug therapy'

These are the very latest articles for this heading:

• Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer. 29 Nov 2009
• Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. 30 Aug 2009
• Pharmacotherapy of endometrial cancer. 30 Jul 2009
• Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition. 30 Jul 2009
• Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. 23 Jul 2009
• Systemic therapy for recurrent endometrial cancer: a review of North American trials. 29 Jun 2009
• Endometrial stromal sarcoma: treatment and patterns of recurrence. 29 Jun 2009
• Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. 29 Jun 2009
• Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study. 29 Jun 2009
• The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer. 29 Jun 2009
• Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? 28 Jun 2009
• A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. 24 Jun 2009
• Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152. 10 Jun 2009
• Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. 7 Jun 2009
• Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study. 21 May 2009
• Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P. 16 May 2009
• Current challenges in clinical management of endometrial cancer. 3 May 2009
• Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer. 29 Apr 2009
• Topotecan-induced long-term remission of an advanced endometrial cancer after treatment with cisplatinum, an anthracycline and paclitaxel. 29 Apr 2009
• Chemo- and radiotherapy in adjuvant management of optimally debulked endometrial cancer. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Endometrial Neoplasms'

Definition: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Descriptor UI: D016889

Alternative terms: Endometrial Neoplasms; Endometrial Neoplasm; Neoplasm, Endometrial; Neoplasms, Endometrial; Endometrial Carcinoma; Carcinoma, Endometrial; Carcinomas, Endometrial; Endometrial Carcinomas; Cancer of Endometrium; Endometrium Cancers; Carcinoma of Endometrium; Endometrium Carcinoma; Endometrium Carcinomas; Cancer of the Endometrium; Endometrial Cancer; Cancer, Endometrial; Cancers, Endometrial; Endometrial Cancers; Endometrium Cancer; Cancer, Endometrium; Cancers, Endometrium;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.945.418.948.585; C13.351.500.852.762.200; C13.351.937.418.875.200;

History Note: 92

Technical Notes: coord IM with histol type of neopl (IM)